107263-89-8 Usage
Description
Thiazole, 4-ethynyl-2-methyl-, is a specialized organic synthetic compound belonging to the family of thiazoles. These aromatic compounds consist of a ring structure made up of one sulfur atom, one nitrogen atom, and three carbon atoms. Thiazole, 4-ethynyl-2-methyl-, is particularly known for its applications in the creation of pharmaceuticals and agrochemicals. Due to their biological and pharmaceutical properties, thiazoles are often utilized in medicinal chemistry for treating various diseases. However, proper handling and usage of this compound are advised, considering its potential reactivity as a synthetic chemical compound. The specific toxicological properties of 4-ethynyl-2-methyl-thiazole are not publicly listed or easily accessible.
Uses
Used in Pharmaceutical Industry:
Thiazole, 4-ethynyl-2-methyl-, is used as a key intermediate in the synthesis of various pharmaceutical compounds for its biological and pharmaceutical properties. It aids in the development of drugs that can treat a range of diseases by interacting with specific biological targets.
Used in Agrochemical Industry:
In the agrochemical industry, Thiazole, 4-ethynyl-2-methyl-, is utilized as a building block for the creation of agrochemicals. These agrochemicals can be used for pest control, weed management, and other agricultural applications, contributing to enhanced crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 107263-89-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,2,6 and 3 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 107263-89:
(8*1)+(7*0)+(6*7)+(5*2)+(4*6)+(3*3)+(2*8)+(1*9)=118
118 % 10 = 8
So 107263-89-8 is a valid CAS Registry Number.
107263-89-8Relevant articles and documents
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 00655; 00659; 00709, (2015/04/22)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
NOVEL HETEROCYCLIC DERIVATIVES AS M-GLU5 ANTAGONISTS
-
Page/Page column 38, (2009/03/07)
This invention relates to novel heterocyclic compounds having selective affinity for the mGlu5 subtype of metabotropic receptors, pharmaceutical compositions thereof and uses for such compounds and compositions in the treatment of lower urinary tract diso
Design, synthesis and biological evaluation of novel, simplified analogues of laulimalide: Modification of the side chain
Paterson, Ian,Menche, Dirk,Hakansson, Anders E.,Longstaff, Adrian,Wong, David,Barasoain, Isabel,Buey, Ruben M.,Diaz, J. Fernando
, p. 2243 - 2247 (2007/10/03)
Novel, simplified analogues of the microtubule-stabilizing anticancer agent laulimalide, including the first derivatives with unnatural side chains, were designed by molecular modelling, synthesized by a late-stage diversification strategy, and evaluated in vitro for growth inhibition of human ovarian carcinoma cell lines (A2780, A2780/AD10).